US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 41.180
  • +2.930+7.66%
Trading Nov 22 12:40 ET
15.85BMarket Cap-7087P/E (TTM)

Moderna Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.13%-1.57B
-39.23%-1.27B
19.27%-989M
-162.60%-3.12B
-62.58%622M
-734.92%-1.6B
-400.99%-915M
-144.34%-1.23B
-63.43%4.98B
-49.79%1.66B
Net income from continuing operations
100.36%13M
7.32%-1.28B
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
Operating gains losses
-75.76%8M
162.86%22M
-27.78%13M
--35M
--19M
--33M
---35M
--18M
----
----
Depreciation and amortization
-79.12%52M
-55.43%41M
-53.85%36M
78.45%621M
152.50%202M
120.35%249M
21.05%92M
-1.27%78M
50.00%348M
2.56%80M
Deferred tax
--0
--0
--0
248.12%828M
-23.26%-106M
1,609.28%1.46B
4.35%-220M
-112.33%-310M
-75.79%-559M
---86M
Other non cash items
-102.70%-1M
150.00%4M
175.00%3M
-75.00%7M
-125.00%-18M
76.19%37M
---8M
---4M
--28M
---8M
Change In working capital
-1,050.00%-1.73B
-125.44%-146M
105.24%60M
95.98%-139M
62.75%249M
120.13%182M
131.63%574M
-28.68%-1.14B
-364.14%-3.46B
111.12%153M
-Change in receivables
14.26%-1.4B
-102.95%-26M
177.57%755M
-72.46%493M
-25.65%974M
-40,750.00%-1.63B
82.40%881M
27,100.00%272M
200.34%1.79B
4,069.70%1.31B
-Change in inventory
-104.82%-11M
-677.78%-104M
-143.06%-93M
51.83%747M
-74.73%285M
246.15%228M
-14.29%18M
143.11%216M
135.29%492M
336.97%1.13B
-Change in prepaid assets
-116.41%-150M
--0
101.42%3M
157.33%974M
119.61%202M
364.93%914M
-22.22%70M
48.79%-212M
-247.44%-1.7B
-239.93%-1.03B
-Change in payables and accrued expense
-83.82%143M
96.92%-7M
-19.87%-712M
-1,400.00%-312M
-195.91%-375M
1,093.26%884M
78.84%-227M
-174.72%-594M
-98.84%24M
-55.47%391M
-Change in other current assets
99.85%-1M
-500.00%-78M
300.00%16M
-2,980.95%-605M
750.00%52M
-7,300.00%-648M
-230.00%-13M
-60.00%4M
136.21%21M
75.76%-8M
-Change in other current liabilities
-97.78%14M
-2,300.00%-110M
1,227.27%124M
743.24%624M
98.84%-2M
31,500.00%632M
-97.72%5M
-144.00%-11M
-47.14%74M
-257.80%-172M
-Change in other working capital
-66.49%-323M
211.88%179M
95.97%-33M
50.45%-2.06B
39.50%-887M
39.56%-194M
89.78%-160M
-1.74%-819M
-247.20%-4.16B
3.43%-1.47B
Cash from discontinued investing activities
Operating cash flow
2.13%-1.57B
-39.23%-1.27B
19.27%-989M
-162.60%-3.12B
-62.58%622M
-734.92%-1.6B
-400.99%-915M
-144.34%-1.23B
-63.43%4.98B
-49.79%1.66B
Investing cash flow
Cash flow from continuing investing activities
-8.62%721M
-15.17%1.65B
-94.13%118M
181.26%4.21B
48.66%-538M
-16.51%789M
268.75%1.94B
151.29%2.01B
39.27%-5.18B
7.91%-1.05B
Net PPE purchase and sale
-7.86%-151M
22.22%-182M
-73.45%-196M
-76.75%-707M
-139.13%-220M
-57.30%-140M
-168.97%-234M
14.39%-113M
-40.85%-400M
23.33%-92M
Net business purchase and sale
--0
--0
--0
---85M
--0
--0
--0
---85M
--0
--0
Net investment purchase and sale
-6.14%872M
-15.93%1.83B
-85.79%314M
206.02%5.02B
67.79%-295M
-10.15%929M
304.51%2.18B
158.30%2.21B
42.31%-4.74B
7.29%-916M
Net other investing changes
----
----
----
42.50%-23M
----
----
----
----
-33.33%-40M
----
Cash from discontinued investing activities
Investing cash flow
-8.62%721M
-15.17%1.65B
-94.13%118M
181.26%4.21B
48.66%-538M
-16.51%789M
268.75%1.94B
151.29%2.01B
39.27%-5.18B
7.91%-1.05B
Financing cash flow
Cash flow from continuing financing activities
118.97%11M
105.09%34M
102.58%14M
60.06%-1.38B
75.11%-109M
94.43%-58M
49.66%-668M
15.58%-542M
-294.96%-3.45B
49.83%-438M
Net issuance payments of debt
104.62%3M
103.57%2M
96.00%-1M
-46.74%-270M
-103.28%-124M
-41.30%-65M
-21.74%-56M
19.35%-25M
-31.43%-184M
-38.64%-61M
Net common stock issuance
14.29%8M
105.23%32M
102.90%15M
66.08%-1.11B
103.98%15M
100.70%7M
52.22%-612M
15.38%-517M
-345.29%-3.26B
54.52%-377M
Cash from discontinued financing activities
Financing cash flow
118.97%11M
105.09%34M
102.58%14M
60.06%-1.38B
75.11%-109M
94.43%-58M
49.66%-668M
15.58%-542M
-294.96%-3.45B
49.83%-438M
Net cash flow
Beginning cash position
-35.11%2.48B
-40.16%2.07B
-8.98%2.93B
-53.10%3.22B
-2.89%2.95B
32.48%3.82B
-31.60%3.46B
-53.10%3.22B
160.24%6.86B
-45.32%3.04B
Current changes in cash
4.14%-833M
13.30%409M
-451.23%-857M
92.07%-289M
-114.20%-25M
-657.05%-869M
116.60%361M
113.56%244M
-186.25%-3.64B
-86.45%176M
End cash Position
-44.23%1.65B
-35.11%2.48B
-40.16%2.07B
-8.98%2.93B
-8.98%2.93B
-2.89%2.95B
32.48%3.82B
-31.60%3.46B
-53.10%3.22B
-53.10%3.22B
Free cash flow
1.32%-1.72B
-26.72%-1.46B
11.43%-1.19B
-183.50%-3.83B
-74.39%402M
-1,167.48%-1.74B
-629.49%-1.15B
-150.86%-1.34B
-65.65%4.58B
-50.78%1.57B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.13%-1.57B-39.23%-1.27B19.27%-989M-162.60%-3.12B-62.58%622M-734.92%-1.6B-400.99%-915M-144.34%-1.23B-63.43%4.98B-49.79%1.66B
Net income from continuing operations 100.36%13M7.32%-1.28B-1,587.34%-1.18B-156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B
Operating gains losses -75.76%8M162.86%22M-27.78%13M--35M--19M--33M---35M--18M--------
Depreciation and amortization -79.12%52M-55.43%41M-53.85%36M78.45%621M152.50%202M120.35%249M21.05%92M-1.27%78M50.00%348M2.56%80M
Deferred tax --0--0--0248.12%828M-23.26%-106M1,609.28%1.46B4.35%-220M-112.33%-310M-75.79%-559M---86M
Other non cash items -102.70%-1M150.00%4M175.00%3M-75.00%7M-125.00%-18M76.19%37M---8M---4M--28M---8M
Change In working capital -1,050.00%-1.73B-125.44%-146M105.24%60M95.98%-139M62.75%249M120.13%182M131.63%574M-28.68%-1.14B-364.14%-3.46B111.12%153M
-Change in receivables 14.26%-1.4B-102.95%-26M177.57%755M-72.46%493M-25.65%974M-40,750.00%-1.63B82.40%881M27,100.00%272M200.34%1.79B4,069.70%1.31B
-Change in inventory -104.82%-11M-677.78%-104M-143.06%-93M51.83%747M-74.73%285M246.15%228M-14.29%18M143.11%216M135.29%492M336.97%1.13B
-Change in prepaid assets -116.41%-150M--0101.42%3M157.33%974M119.61%202M364.93%914M-22.22%70M48.79%-212M-247.44%-1.7B-239.93%-1.03B
-Change in payables and accrued expense -83.82%143M96.92%-7M-19.87%-712M-1,400.00%-312M-195.91%-375M1,093.26%884M78.84%-227M-174.72%-594M-98.84%24M-55.47%391M
-Change in other current assets 99.85%-1M-500.00%-78M300.00%16M-2,980.95%-605M750.00%52M-7,300.00%-648M-230.00%-13M-60.00%4M136.21%21M75.76%-8M
-Change in other current liabilities -97.78%14M-2,300.00%-110M1,227.27%124M743.24%624M98.84%-2M31,500.00%632M-97.72%5M-144.00%-11M-47.14%74M-257.80%-172M
-Change in other working capital -66.49%-323M211.88%179M95.97%-33M50.45%-2.06B39.50%-887M39.56%-194M89.78%-160M-1.74%-819M-247.20%-4.16B3.43%-1.47B
Cash from discontinued investing activities
Operating cash flow 2.13%-1.57B-39.23%-1.27B19.27%-989M-162.60%-3.12B-62.58%622M-734.92%-1.6B-400.99%-915M-144.34%-1.23B-63.43%4.98B-49.79%1.66B
Investing cash flow
Cash flow from continuing investing activities -8.62%721M-15.17%1.65B-94.13%118M181.26%4.21B48.66%-538M-16.51%789M268.75%1.94B151.29%2.01B39.27%-5.18B7.91%-1.05B
Net PPE purchase and sale -7.86%-151M22.22%-182M-73.45%-196M-76.75%-707M-139.13%-220M-57.30%-140M-168.97%-234M14.39%-113M-40.85%-400M23.33%-92M
Net business purchase and sale --0--0--0---85M--0--0--0---85M--0--0
Net investment purchase and sale -6.14%872M-15.93%1.83B-85.79%314M206.02%5.02B67.79%-295M-10.15%929M304.51%2.18B158.30%2.21B42.31%-4.74B7.29%-916M
Net other investing changes ------------42.50%-23M-----------------33.33%-40M----
Cash from discontinued investing activities
Investing cash flow -8.62%721M-15.17%1.65B-94.13%118M181.26%4.21B48.66%-538M-16.51%789M268.75%1.94B151.29%2.01B39.27%-5.18B7.91%-1.05B
Financing cash flow
Cash flow from continuing financing activities 118.97%11M105.09%34M102.58%14M60.06%-1.38B75.11%-109M94.43%-58M49.66%-668M15.58%-542M-294.96%-3.45B49.83%-438M
Net issuance payments of debt 104.62%3M103.57%2M96.00%-1M-46.74%-270M-103.28%-124M-41.30%-65M-21.74%-56M19.35%-25M-31.43%-184M-38.64%-61M
Net common stock issuance 14.29%8M105.23%32M102.90%15M66.08%-1.11B103.98%15M100.70%7M52.22%-612M15.38%-517M-345.29%-3.26B54.52%-377M
Cash from discontinued financing activities
Financing cash flow 118.97%11M105.09%34M102.58%14M60.06%-1.38B75.11%-109M94.43%-58M49.66%-668M15.58%-542M-294.96%-3.45B49.83%-438M
Net cash flow
Beginning cash position -35.11%2.48B-40.16%2.07B-8.98%2.93B-53.10%3.22B-2.89%2.95B32.48%3.82B-31.60%3.46B-53.10%3.22B160.24%6.86B-45.32%3.04B
Current changes in cash 4.14%-833M13.30%409M-451.23%-857M92.07%-289M-114.20%-25M-657.05%-869M116.60%361M113.56%244M-186.25%-3.64B-86.45%176M
End cash Position -44.23%1.65B-35.11%2.48B-40.16%2.07B-8.98%2.93B-8.98%2.93B-2.89%2.95B32.48%3.82B-31.60%3.46B-53.10%3.22B-53.10%3.22B
Free cash flow 1.32%-1.72B-26.72%-1.46B11.43%-1.19B-183.50%-3.83B-74.39%402M-1,167.48%-1.74B-629.49%-1.15B-150.86%-1.34B-65.65%4.58B-50.78%1.57B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.72%